EMILY
MULLIN
SCIENCE + BIOTECH
JOURNALIST
A science journalist with more than a decade's worth of experience, I'm currently a health reporter at the Pittsburgh Post-Gazette and a monthly contributor at WIRED.
In fall 2021, I was an MIT Knight Science Journalism project fellow, and before that, I covered the intersection of biotechnology and society as a staff writer at OneZero, Medium's tech and science publication. At OneZero, I wrote about a dubious $1 million pay-to-participate study to reverse aging, a government program to make radiation-proof soldiers and the ethics of trying to "cure" inherited deafness.
Previously, I served as associate editor for biomedicine at MIT Technology Review, where I won a Newsbrief Award from the D.C. Science Writers Association for a story about a menstrual-cycle-on-a chip. I was also a 2018 finalist for an NIHCM Foundation Journalism Award for my coverage of a New York fertility doctor advertising a fertility procedure that remains illegal in the United States.
Over the years, my freelance stories have appeared in The Washington Post, New York Times, Wall Street Journal, Scientific American, National Geographic, Smithsonian Magazine, STAT and other outlets.
I started my career at the Baltimore Business Journal, where I followed the high-profile case of a Maryland cardiologist accused of implanting unnecessary heart stents in patients. I have a bachelor's degree in journalism from Ohio University and a master's in science writing from Johns Hopkins University.
